These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 15589741)
21. Simultaneous administration of a low-dose mixture of donor bone marrow cells and splenocytes plus adenovirus containing the CTLA4Ig gene result in stable mixed chimerism and long-term survival of cardiac allograft in rats. Jin Y; Zhang Q; Hao J; Gao X; Guo Y; Xie S Immunology; 2003 Oct; 110(2):275-86. PubMed ID: 14511242 [TBL] [Abstract][Full Text] [Related]
22. Methyl-Guanine-Methyl-Transferase Transgenic Bone Marrow Transplantation Allows N,N-bis(2-chloroethyl)-Nitrosourea Driven Donor Mixed-Chimerism Without Graft-Versus-Host Disease, and With Donor-Specific Allograft Tolerance. Hu M; Kramer B; Zhang GY; Wang YM; Watson D; Howden B; McCowage G; Alexander IE; Gunning P; Alexander SI Transplantation; 2015 Dec; 99(12):2476-84. PubMed ID: 26177088 [TBL] [Abstract][Full Text] [Related]
23. CD8 T cell of donor splenocyte mixed with bone marrow cells is more effective than CD4 T cell for induction of donor-specific tolerance in sublethally irradiated mice. Yoshida A; Narumi S; Hashimoto N; Itabashi Y; Hakamada K; Sasaki M Transplant Proc; 2004 Oct; 36(8):2418-22. PubMed ID: 15561266 [TBL] [Abstract][Full Text] [Related]
24. Mixed chimerism achieved by a nonlethal conditioning regimen induces donor-specific tolerance to lung allografts. Li S; Salgar SK; Kurimoto Y; Yousem S; Pham SM J Surg Res; 2008 May; 146(2):289-97. PubMed ID: 18314139 [TBL] [Abstract][Full Text] [Related]
25. [Allogeneic chimerism induced by B7 antisense peptide pre-treated splenocytes prolongs the survival of allograft in mice]. Chen J; Zhang RH; Liu QS; Chu YW; He QZ; Xiong SD Zhonghua Yi Xue Za Zhi; 2004 Jan; 84(2):138-41. PubMed ID: 14990131 [TBL] [Abstract][Full Text] [Related]
26. Role of thymus in operational tolerance induction in limb allograft transplant model. Siemionow M; Izycki D; Ozer K; Ozmen S; Klimczak A Transplantation; 2006 Jun; 81(11):1568-76. PubMed ID: 16770246 [TBL] [Abstract][Full Text] [Related]
27. Splenocytes can replace chimeric cells and maintain allograft tolerance. Hayashi Y; Yamazaki S; Kanamoto A; Takayama T Transplantation; 2007 Nov; 84(9):1168-73. PubMed ID: 17998873 [TBL] [Abstract][Full Text] [Related]
28. Lack of correlation between an assay used to determine early marrow allograft rejection and long-term chimerism after murine allogeneic bone marrow transplantation: effects of marrow dose. Koh CY; Welniak LA; Murphy WJ Biol Blood Marrow Transplant; 2005 Apr; 11(4):252-9. PubMed ID: 15812390 [TBL] [Abstract][Full Text] [Related]
29. Bone marrow chimerism and tolerance induced by single-dose cyclophosphamide. Okayama J; Ko S; Kanehiro H; Kanokogi H; Hisanaga M; Ohashi K; Sho M; Nagao M; Ikeda N; Kanamura T; Akashi S; Nakajima Y J Surg Res; 2004 Jul; 120(1):102-10. PubMed ID: 15172196 [TBL] [Abstract][Full Text] [Related]
30. Application of chimerism-based drug-induced tolerance to rat into mouse xenotransplantation. Tomita Y; Shimizu I; Iwai T; Zhang QW; Okano S; Kajiwara T; Onzuka T; Tominaga R Scand J Immunol; 2006 Oct; 64(4):392-7. PubMed ID: 16970680 [TBL] [Abstract][Full Text] [Related]
31. Role of the CTLA4 pathway in hyporesponsiveness induced by intratracheal delivery of alloantigen. Shirasugi N; Akiyama Y; Aramaki O; Shibutani S; Matsumoto K; Bashuda H; Yagita H; Okumura K; Ikeda Y; Niimi M Transplantation; 2003 May; 75(10):1636-9. PubMed ID: 12777848 [TBL] [Abstract][Full Text] [Related]
33. B7.2-/- mature dendritic cells generate T-helper 2 and regulatory T donor cells in fetal mice after in utero allogeneic bone marrow transplantation. Bhattacharyya S; Cowan MJ Biol Blood Marrow Transplant; 2005 Sep; 11(9):657-71. PubMed ID: 16125636 [TBL] [Abstract][Full Text] [Related]
34. A combination of anergic cells' adoptive transfer and rapamycin therapy prolongs cardiac allograft survival in mice. Cai Y; Tang XD; Zhou PJ Scand J Immunol; 2005 Mar; 61(3):266-73. PubMed ID: 15787744 [TBL] [Abstract][Full Text] [Related]
35. [Pretreatment of donor dendritic cells with NBD-peptide prolongs mouse cardiac allograft survival]. Su G; Zhao WZ; Chen JJ; Xu J; Qiao CH; Liu C; Sun ZQ Nan Fang Yi Ke Da Xue Xue Bao; 2008 Aug; 28(9):1562-7. PubMed ID: 18819868 [TBL] [Abstract][Full Text] [Related]
36. A more persistent tolerance to islet allografts through bone marrow transplantation in minimal nonmyeloablative conditioning therapy. Lee BW; Lee JI; Oh SH; Ahn YR; Chae HY; Lee MS; Lee MK; Kim KW Transplant Proc; 2005 Jun; 37(5):2266-9. PubMed ID: 15964395 [TBL] [Abstract][Full Text] [Related]
37. Long-term (>1 year) analyses of chimerism and tolerance in mixed allogeneic chimeric mice using normal mouse combinations. Hayashi H; Toki J; Zhexiong L; Sugiura K; Inoue K; Ikehara S Stem Cells; 2000; 18(4):273-80. PubMed ID: 10924093 [TBL] [Abstract][Full Text] [Related]
38. Prolonged limb allograft survival with CD 40 costimulation blockade, T-cell depletion, and megadose donor bone-marrow transfusion. Tung TH; Mackinnon SE; Mohanakumar T Microsurgery; 2005; 25(8):624-31. PubMed ID: 16281278 [TBL] [Abstract][Full Text] [Related]
39. Addition of cyclophosphamide to T-cell depletion-based nonmyeloablative conditioning allows donor T-cell engraftment and clonal deletion of alloreactive host T-cells after bone marrow transplantation. Xu H; Chilton PM; Huang Y; Schanie CL; Yan J; Ildstad ST Transplantation; 2007 Apr; 83(7):954-63. PubMed ID: 17460568 [TBL] [Abstract][Full Text] [Related]
40. Allogeneic intra-BM-BMT plus adult thymus transplantation from same donor has benefits for long-term survival even after sublethal irradiation or low-dose BM cell injection. Nishida T; Hosaka N; Takaki T; Miyake T; Cui W; Inaba M; Kinoshita H; Matsuda T; Ikehara S Bone Marrow Transplant; 2009 Jun; 43(11):829-37. PubMed ID: 19079314 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]